Andere Sprachen Dr. Lal PathLabs Limited Bombay S.E.

Aktien

A2ACT9

INE600L01024

LALPATHLAB

Verzögert Bombay S.E. Andere Börsenplätze 07:07:57 30.04.2024			% 5 Tage	% 1. Jan.
2 361 ^INR	+0,53 %		+5,22 %	-8,16 %

26.04.	Dr. Lal Pathlabs Limited gibt den Rücktritt von Bharath U als Chief Executive Officer mit Wirkung zum 9. Mai 2024 bekannt	CI
18.03.	Dr Lal Pathlabs ernennt CEO	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer, Effective May 9, 2024	26.04.
Dr Lal Pathlabs Names CEO	18.03.
Dr. Lal PathLabs Limited Appoints Shankha Banerjee as Chief Executive Officer, Effective May 21, 2024	17.03.
Dr. Lal Pathlabs Limited Announces Resignation of Bharath U as Chief Executive Officer	03.03.
Dr. Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q3; EPS, Revenue Miss Estimates	02.02.
Dr. Lal PathLabs Seeks M&A	01.02.
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	01.02.
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Fiscal Year 2023-24	01.02.
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01.02.
Dr. Lal Pathlabs Board to Consider Second Interim Dividend for Fiscal 2024	25.01.
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q2; Shares Climb 5%	03.11.
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02.11.
Dr. Lal Pathlabs Limited Approves to Declare Final Dividend for the Financial Year Ended March 31, 2023	12.09.23
Dr. Lal PathLabs Limited Announces Change in Directorate	20.08.23
Dr Lal Pathlabs' Consolidated Profit Jumps in Fiscal Q1; Revenue Meets Estimates	31.07.23
Dr. Lal PathLabs Seeks Inorganic Opportunity	27.07.23
Dr. Lal Pathlabs Limited Proposes Interim Dividend for the Financial Year 2023-24	27.07.23
Dr. Lal PathLabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27.07.23
Dr. Lal PathLabs Limited acquired additional 10% stake in Aprl Pathlabs Private Limited.	27.07.23
Dr. Lal PathLabs' Consolidated Net Profit Declines in Fiscal Q4; Shares Up 3%	12.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dr. Lal PathLabs Limited Bombay S.E.

Aktien

A2ACT9

INE600L01024

LALPATHLAB

Andere Sprachen

Filter